Lilly Lowers Forecast on Weight-Loss Disappointment
October 30, 2024
4,879
28
8
0.74%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Television Episodes Around October 30, 2024
See what was published immediately before and after this episode.
3:36Now PlayingLilly Lowers Forecast on Weight-Loss Disappointment
YouTube Description
as posted by the channelEli Lilly & Co. lowered guidance on lackluster sales of its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro. Madison Muller reports on "Bloomberg Open Interest."
Sign up for the Supply Lines newsletter to stay informed on the latest developments of global supply chains
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.